Exozymes (EXOZ) Other Operating Expenses (2023 - 2026)
Exozymes (EXOZ) posted quarterly Other Operating Expenses of $3.5 million for Q4 2025, up 357.82% year-over-year from $755492.4 in Q4 2024, and up 1714.89% quarter-over-quarter from -$214181.0 in Q3 2025.
Exozymes (EXOZ) Other Operating Expenses (2023 - 2026) Analysis & Trends
Exozymes (EXOZ) has reported Other Operating Expenses for 3 consecutive years, with $3.5 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Other Operating Expenses rose 357.82% year-over-year to $3.5 million; the TTM figure through Dec 2025 stood at $3.5 million (up 734.46% YoY), while the FY2025 annual figure was $2.8 million, up 941.75% from the prior year.
- Other Operating Expenses rose to $3.5 million in Q4 2025 per EXOZ's latest filing, from -$214181.0 in the prior quarter.
- Across five years, Other Operating Expenses topped out at $3.5 million in Q4 2025 and bottomed at -$1.3 million in Q4 2024.
- Historically, Other Operating Expenses has averaged $275721.0 across 3 years, with a median of -$68138.5 in 2023.
- Annual changes were most pronounced in 2024 — Other Operating Expenses tumbled 1658.45% — and 2025, when it soared 926.38%.
- Exozymes' Other Operating Expenses stood at -$76292.0 in 2023, then sank by 1658.45% to -$1.3 million in 2024, then soared by 357.82% to $3.5 million in 2025.
- Business Quant data shows EXOZ's Other Operating Expenses at $3.5 million in Q4 2025, -$214181.0 in Q3 2025, and $495707.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Exozymes | 62.35 Mn | 62.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -161,422.00 |
| Dec 31, 2025 | 3.46 Mn |
| Sep 30, 2025 | -214,181.00 |
| Jun 30, 2025 | 495,707.00 |
| Mar 31, 2025 | -204,236.00 |
| Dec 31, 2024 | -1.34 Mn |
| Sep 30, 2024 | 650,886.00 |
| Jun 30, 2024 | -59,985.00 |
| Mar 31, 2024 | 193,313.00 |
| Dec 31, 2023 | -76,292.00 |
| Sep 30, 2023 | -145,244.00 |